Lesaffre expands its international development in plant health with the acquisition of an Ohio-based company

PARIS and VAN WERT, Ohio, May 4, 2021 /PRNewswire/ — Lesaffre announces the acquisition of ABM, Advanced Biological Marketing, a company specializing in the development of bionutrient products for field crops in the American Midwest. With this acquisition, Agrauxine by Lesaffre, Lesaffre’s business unit specializing in crop protection, is strengthening its presence in United States.

Lesaffre accelerates its development in the world’s largest biosolutions market

A world player in the field of fermentation and micro-organisms, Lesaffre has been present for United States since the 1980s and has expanded its manufacturing capabilities since then. Lesaffre currently employs more than 500 people at its various manufacturing sites and marketing centers in the United States.

Today, the company announces the acquisition of ABM, a company based in Van Wert (Ohio), specialized in the treatment of seeds with bionutrient products. ABM’s teams will join those of Agrauxine by Lesaffre, Lesaffre’s business unit dedicated to crop protection. Agrauxine by Lesaffre has been developing biosourced solutions for plant nutrition and health for more than 15 years.

Agrauxine by Lesaffre wishes to accelerate its development by United States with this purchase. With the integration of ABM, the business unit now has nearly 40 employees in the country.

“This acquisition is part of our strategy to develop new solutions from micro-organisms, such as yeasts, bacteria and fungi, which respect the environment. Our R&D teams are innovating on a daily basis in this ambition. Thanks to ABM, our scope of crop bioprotection has been expanded,” said Antoine Baule, CEO of Lesaffre.

Complementary expertise allowing synergies

This acquisition represents a good step in the development of Agrauxine by Lesaffre and enables it to achieve strong complementarities in terms of market access as well as in terms of ranges of biocontrol and biostimulation products.

“Following the merger with ABM, we are taking on a whole new dimension in the American market. We have strong ambitions for growth in this market and this local presence, as close as possible to our customers, will be a considerable asset”, adds Hugo Bony, CEO of Agrauxine by Lesaffre.

Agrauxine will continue ABM projects, including two new biocontrol technologies. These strategic technologies will be commercialized on the American market in the coming years.

“The acquisition of ABM by Agrauxine brings together two companies that develop innovative products with unique formulations. This partnership creates the first company of its kind to contribute its expertise in biological seed treatment, biostimulants and foliar biopesticides for a complete line of organic products. brilliant as our companies will combine their expertise in R&D, manufacturing, sales and marketing to continue to provide innovative solutions to our customers in North America and all over the world, said Dan Custis, CEO of ABM.

About ABM, Advanced Organic Marketing

Founded by farmers, agronomists and agricultural consultants,Advanced Organic Marketing (ABM) is dedicated to researching new technologies for the agricultural seed treatment market. ABM focuses on the farmer, both domestically and internationally, and is dedicated to increasing production and profitability of production. ABM develops, manufactures and produces the best agricultural biologics and other seed treatments to increase yields and improve agricultural productivity. ABM offers a product line of over 20 proven organic root inoculants for growers around the world

About Agrauxine

Created in 2014, Agrauxine is Lesaffre’s business unit dedicated to biosolutions for crop production. Today, it is a key technical and industrial player in biocontrol, biostimulation and bionutrition, through its solutions based on micro-organisms or their derivatives.

The company has 66 employees spread over 3 continents (North America, South America and Europe), more than a quarter of which are focused on technical research and development. Agrauxine is commercially present in 35 countries.

More information on www.agrauxine.com

About Lesaffre

A key global player in fermentation for more than a century, Lesaffre, with a 2.2 billion euros turnover, and established on all continents, has 10,700 employees of more than 85 nationalities. On the strength of this experience and this diversity, we work with our customers, partners and researchers to find ever more relevant responses to the needs for food, health, naturalness and respect for our environment. Thus, every day, we explore and reveal the infinite potential of microorganisms.

Healthy feeding of 9 billion people by 2050, by making the best use of our planet’s resources, is a major and unprecedented challenge. We believe that fermentation is one of the most promising answers to this challenge.

Lesaffre – Together to better feed and protect the planet

More information on www.lesaffre.com
Join us on LinkedIn and Twitter

Contact: Cindy Hackman, CLUTCH, 636-544-6657, [email protected]

SOURCE Lesaffre

Comments are closed.